| Breakdown | TTM | Mar 2025 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 208.63B | 208.46B | 203.96B | 220.31B | 201.66B | 145.96B |
| Gross Profit | 34.95B | 34.15B | 31.77B | 32.66B | 33.18B | 24.86B |
| EBITDA | 18.71B | 18.54B | 16.82B | 17.71B | 18.50B | 11.56B |
| Net Income | 13.69B | 13.50B | 4.46B | 10.59B | 9.79B | 6.26B |
Balance Sheet | ||||||
| Total Assets | 255.25B | 264.26B | 265.86B | 251.06B | 244.67B | 226.00B |
| Cash, Cash Equivalents and Short-Term Investments | 52.89B | 61.09B | 60.82B | 44.40B | 33.99B | 48.86B |
| Total Debt | 9.43B | 1.01B | 678.00M | 1.40B | 1.41B | 58.00M |
| Total Liabilities | 46.01B | 49.14B | 52.03B | 49.15B | 52.73B | 45.70B |
| Stockholders Equity | 189.82B | 194.82B | 189.71B | 179.81B | 170.48B | 162.70B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 5.93B | 17.81B | 11.16B | -18.58B | 10.43B |
| Operating Cash Flow | 0.00 | 11.31B | 21.52B | 17.34B | -10.64B | 17.15B |
| Investing Cash Flow | 0.00 | -6.74B | -809.00M | -3.16B | -1.99B | -4.67B |
| Financing Cash Flow | 0.00 | -12.51B | -5.36B | -5.09B | -1.23B | -4.00B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | ¥769.52B | 9.48 | 10.78% | 4.68% | -1.97% | 47.63% | |
74 Outperform | ¥215.58B | 14.50 | 6.87% | 5.25% | -1.43% | 171.44% | |
74 Outperform | ¥396.63B | 9.05 | 6.16% | 2.99% | -0.02% | -40.45% | |
67 Neutral | ¥3.22T | 12.26 | -0.26% | 4.53% | 1.31% | -101.19% | |
67 Neutral | ¥186.49B | 11.58 | 5.06% | 1.80% | 4.10% | 152.90% | |
64 Neutral | ¥1.13T | 9.28 | 2.09% | 4.59% | -8.07% | -41.42% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% |